During the past decade, Affinity Clinical Research, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affinity Clinical Research, LLC" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Affinity Clinical Research, LLC" are "COVID-19" (2 trials). Many other conditions were trialed in "Affinity Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Affinity Clinical Research, LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PUL-042 Inhalation Solution" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Affinity Clinical Research, LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Affinity Clinical Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Affinity Clinical Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affinity Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".